Praxis Precision Medicines (PRAX) Cash & Current Investments (2022 - 2025)
Historic Cash & Current Investments for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to $267.2 million.
- Praxis Precision Medicines' Cash & Current Investments fell 2517.28% to $267.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $267.2 million, marking a year-over-year decrease of 2517.28%. This contributed to the annual value of $392.6 million for FY2024, which is 38286.22% up from last year.
- Praxis Precision Medicines' Cash & Current Investments amounted to $267.2 million in Q3 2025, which was down 2517.28% from $301.3 million recorded in Q2 2025.
- In the past 5 years, Praxis Precision Medicines' Cash & Current Investments registered a high of $392.6 million during Q4 2024, and its lowest value of $56.0 million during Q2 2022.
- In the last 4 years, Praxis Precision Medicines' Cash & Current Investments had a median value of $124.3 million in 2023 and averaged $190.1 million.
- Per our database at Business Quant, Praxis Precision Medicines' Cash & Current Investments surged by 38286.22% in 2024 and then tumbled by 2517.28% in 2025.
- Quarter analysis of 4 years shows Praxis Precision Medicines' Cash & Current Investments stood at $61.6 million in 2022, then soared by 31.95% to $81.3 million in 2023, then surged by 382.86% to $392.6 million in 2024, then plummeted by 31.95% to $267.2 million in 2025.
- Its Cash & Current Investments stands at $267.2 million for Q3 2025, versus $301.3 million for Q2 2025 and $328.0 million for Q1 2025.